Effects of sulpiride induced hyperprolactinaemia in patients with Turner's syndrome

Clin Endocrinol (Oxf). 1980 Jul;13(1):9-16. doi: 10.1111/j.1365-2265.1980.tb01017.x.

Abstract

In order to evaluate the interference of prolactin (PRL) on some aspects of pituitary-gonadal derangement observed in patients with hyperprolactinaemic amenorrhoea (HA), a GnRH stimulation test (100 micrograms i.v.) was performed on twenty-one patients with hyperprolactinaemia without evidence of pituitary tumour and in nine subjects with Turner's syndrome (TS) before and after sulpiride administration (200 mg/day orally, for 3 months). In patients with HA an enhanced response of gonadotrophins to GnRH was observed. In patients with TS a further increase of the gonadotrophin hyper-responsiveness to the releasing hormone occurred when hyperprolactinaemia was induced by chronic sulpiride administration. Since, in these patients, appreciable ovarian steroidogenesis is lacking, a direct effect of the increased plasma PRL at the hypothalamo-pituitary level is likely. In hyperprolactinaemic amenorrhoea pituitary hyper-responsiveness may not be due to PRL effects on ovarian steroidogenesis.

MeSH terms

  • Adolescent
  • Adult
  • Amenorrhea / blood
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Luteinizing Hormone / blood
  • Pituitary Hormone-Releasing Hormones
  • Prolactin / blood*
  • Sulpiride / therapeutic use*
  • Turner Syndrome / blood*
  • Turner Syndrome / drug therapy

Substances

  • Pituitary Hormone-Releasing Hormones
  • Estradiol
  • Sulpiride
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone